Article
Mitochondrial subhaplogroups and differential risk of stavudine-induced lipodystrophy in Malawian HIV/AIDS patients.
Pharmacogenomics - 1 Dec 2013
Kampira Elizabeth, Kumwenda Johnstone, Van Oosterhout Joep J, Dandara Collet
Abstract excerpt
BACKGROUND & AIM: Lipodystrophy remains a significant problem in HIV/AIDS patients, especially those on regimens containing either protease inhibitors or thymidine analogs (stavudine or zidovudine). Many of the manifestations of lipodystrophy have been linked to mitochondrial dysfunction. We set out to investigate whether mtDNA variation is associated with the development of stavudine-induced lipodystrophy among...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
